ResearcherMayo ClinicActive in the last 2 years
Alexander Dean Sherry
Matched on ORCID iD 0000-0001-5115-1691; OpenAlex author ID A5017883501. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 24
2024: 1 paper · 2025: 2 papers · 2026: 1 paper
Papers 4
- The PREOPANC-2 trial in resectable and borderline resectable pancreatic cancer. Co-author DOI 10.1016/s1470-2045(25)00666-7↗
- Evolving Paradigms in the Treatment of Oligometastatic Pancreatic Ductal Adenocarcinoma. First author DOI 10.1007/s12029-024-01145-0↗
- Contemporary Advances, Evidence, and Considerations in Preoperative Therapy for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.semradonc.2025.07.007↗
- Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II T… First author DOI 10.1200/jco.24.00081↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ethan Bernard Ludmir · 3 shared papers, 2024–2026 · strength 0.81
- Paper The PREOPANC-2 trial in resectable and borderline resectable pancreatic cancer. DOI 10.1016/s1470-2045(25)00666-7↗
- Paper Evolving Paradigms in the Treatment of Oligometastatic Pancreatic Ductal Adenocarcinoma. DOI 10.1007/s12029-024-01145-0↗
- Paper Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEN… DOI 10.1200/jco.24.00081↗
- Krishan R. Jethwa · 2 shared papers, 2025–2026 · strength 0.76
- Albert C. Koong · 2 shared papers, 2024–2025 · strength 0.38
- Chad Z. Tang · 2 shared papers, 2024–2025 · strength 0.38
- Eugene Jon Koay · 2 shared papers, 2024–2025 · strength 0.38
- Shubham Pant · 2 shared papers, 2024–2025 · strength 0.38
- Alexandra K. Bennett · 1 shared paper, 2025 · strength 0.33
- Mark Joseph Truty · 1 shared paper, 2025 · strength 0.33
- Ryan Michael Carr · 1 shared paper, 2025 · strength 0.33
- Jakob Liermann · 1 shared paper, 2025 · strength 0.23
- Enoch Chang · 1 shared paper, 2025 · strength 0.23
- Todd Anthony Aguilera · 1 shared paper, 2025 · strength 0.23
- Ching-Wei David Tzeng · 1 shared paper, 2025 · strength 0.23
- Suyu Liu · 1 shared paper, 2024 · strength 0.15
- Matthew H. G. Katz · 1 shared paper, 2024 · strength 0.15
- Dan Zhao · 1 shared paper, 2024 · strength 0.15
- Jason A. Willis · 1 shared paper, 2024 · strength 0.15
- Michael S. Lee · 1 shared paper, 2024 · strength 0.15
- Grace L. Smith · 1 shared paper, 2024 · strength 0.15
- Robert A. Wolff · 1 shared paper, 2024 · strength 0.15
- Cullen M. Taniguchi · 1 shared paper, 2024 · strength 0.15
- Brandon George Smaglo · 1 shared paper, 2024 · strength 0.15
- Ryan W. Huey · 1 shared paper, 2024 · strength 0.15
- Lorenzo G. Cohen · 1 shared paper, 2024 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.